Clinical Trials & Rare Diseases
- Identify areas of opportunity by evaluating trial trends by disease
- Evaluate competitors' clinical strategies, including endpoints, inclusion and exclusion criteria
- Validate feasibility by analyzing trends in trial failures and outcomes
- An in-depth list of 4,815 rare diseases
- A complete database of FDA-designated orphan drugs and condition pairs
- 16,538 biological entities mentioned in rare disease trials
Key Benefits
Get started faster
Skip the cleanup and start working sooner with clean, ready-to-use data.
Evaluate trends across categories
Dig into pharmacological, physiochemical, and therapeutic categories.
Access exhaustive data in one spot
Chemical structures, drug targets, ADMET, trials, clinical details, and more.
Enhance Your Analysis
Map your datasets to ours using our comprehensive identifiers & cross-walks.
Leverage expert support
Get documentation & dedicated support to help you succeed.
Better Together
Paired with the FDA's clinical trial dataset, this add-on provides clean and usable data ready for query and further analysis:
| FDA and Clinical Trials & Rare Diseases | FDAs Open-Source Data Alone | |
|---|---|---|
Normalized & mapped to ontologies | Data requires cleaning & normalization | |
Several structured fields Trial failure reasons, intervention mapping, relationships to targets, and more | Inconsistent formatting, which causes parsing failures | |
Curated by medical experts | Unrestricted values, making it hard to define or broaden queries | |
Richly connects with other data | Does not connect you to other data |